Acute Heart Failure (AHF)
35
18
19
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
2.9%
1 terminated out of 35 trials
80.0%
-6.6% vs benchmark
23%
8 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (35)
Comprehensive Clinical Prediction Rule for Acute Heart Failure
Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE
Implementation of Acute Heart Failure Checklist
Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)
Assessment of Residual Congestion in Acute Decompensated Heart Failure
Evaluation of Fibroscan® Performance in Diagnosing Acute Heart Failure in Patients Presenting to the Emergency Department
Sarcopenia in Older Patients Hospitalized for Acute Heart Failure.
Digoxin After Acute Heart Failure (DIG-DICA)
Acute Heart Failure Registry
Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions
Urinary Chloride and Sodium Changes and Residual Congestion in Acute Heart Failure
ReDS-Guided Decongestion in Acute Heart Failure (ReDS-LATAM HF)
TACTIC-HF: Sequential Diuretic Strategies in Ambulatory Worsening Heart Failure
Restrictive Versus Liberal Fluid Intake in Acute Decompensated Heart Failure
Training Medical Residents in the Use of the Venous Excess UltraSound (VExUS) Score for Bedside Volume Assessment.
Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure
ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure
POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure
Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure